| SNo |
IS Number |
Title |
Technical Committee |
|
1 |
IS/ISO 10993 : Part 3 : 2014 |
Biological evaluation of medical devices Part 3 Tests for Genotoxicity, Carcinogenicity and Reproductive toxicity (First Revision) |
MHD 19 |
|
2 |
IS/ISO 10993 : Part 5 : 2009 |
Biological evaluation of medical devices Part 5 Tests for in vitro cytotoxicity |
MHD 19 |
|
3 |
IS/ISO 10993 : Part 6 : 2016 |
Biological evaluation of medical devices Part 6 Tests for local effects after implantation |
MHD 19 |
|
4 |
IS/ISO 10993 : Part 10 : 2010 |
Biological evaluation of medical devices Part 10 Tests for irritation and skin sensitization |
MHD 19 |
|
5 |
IS/ISO 10993 : Part 11 : 2017 |
Biological evaluation of medical devices Part 11 Tests for systemic toxicity |
MHD 19 |
|
6 |
IS 11135 : 1984 |
Metoxuron, Technical |
FAD 1 |
|
7 |
IS/ISO 11137 : Part 1 : 2006 |
Sterilization of health care products - Radiation: Part 1 requirements for development, validation and routine control of a sterilization process for medical devices |
MHD 12 |
|
8 |
IS/ISO 11137 : Part 2 : 2013 |
Sterilization of health care products - Radiation: Part 2 establishing the sterilization dose |
MHD 12 |
|
9 |
IS/ISO 15223 : Part 1 : 2016 |
Medical Devices — Symbols to be Used with Medical Device Labels, Labelling and Information to be Supplied Part 1 General Requirements ( Second Revision ) |
MHD 14 |
|
10 |
IS/ISO 15223 : Part 2 : 2010 |
Medical devices - Symbols to be used with medical device labels, labelling, and information to be supplied: Part 2 symbol development, selection and validation |
MHD 14 |
|
11 |
IS 9298 : Part 2 : 1980 |
Specification for television pattern generators: Part 2 methods of measurements |
LITD 8 |
